Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation

L Wu, E Seung, L Xu, E Rao, DM Lord, RR Wei… - Nature Cancer, 2020 - nature.com
Despite the significant therapeutic advances provided by immune-checkpoint blockade and
chimeric antigen receptor T cell treatments, many malignancies remain unresponsive to …
被引用次数：197 相关文章

Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell rec

L Wu, E Seung, L Xu, E Rao, DM Lord, RR Wei… - Nat. Cancer, 2020 - osti.gov
Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell
rec (Journal Article) | OSTI.GOV skip to main content Sign In Create Account Show search Show …

Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation

L Wu, E Seung, L Xu, E Rao, DM Lord… - Nature …, 2020 - pubmed.ncbi.nlm.nih.gov
Despite the significant therapeutic advances provided by immune-checkpoint blockade and
chimeric antigen receptor T cell treatments, many malignancies remain unresponsive to …

Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation.

L Wu, E Seung, L Xu, E Rao, DM Lord, RR Wei… - Nature Cancer, 2019 - europepmc.org
Despite the significant therapeutic advances provided by immune-checkpoint blockade and
chimeric antigen receptor T cell treatments, many malignancies remain unresponsive to …